DI STEFANO, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 6.169
EU - Europa 5.562
AS - Asia 3.154
SA - Sud America 261
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 3
Totale 15.178
Nazione #
US - Stati Uniti d'America 6.102
IT - Italia 1.318
SG - Singapore 1.249
CN - Cina 988
IE - Irlanda 857
UA - Ucraina 783
SE - Svezia 610
GB - Regno Unito 606
TR - Turchia 533
FR - Francia 486
DE - Germania 355
BR - Brasile 237
IN - India 229
FI - Finlandia 186
RU - Federazione Russa 138
HK - Hong Kong 53
CA - Canada 49
BE - Belgio 46
CZ - Repubblica Ceca 35
AT - Austria 34
VN - Vietnam 28
ES - Italia 19
IR - Iran 19
PL - Polonia 19
BD - Bangladesh 15
NL - Olanda 14
GR - Grecia 11
EU - Europa 10
LT - Lituania 9
MX - Messico 9
AR - Argentina 7
TN - Tunisia 7
CH - Svizzera 6
JP - Giappone 6
EC - Ecuador 5
IQ - Iraq 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
AZ - Azerbaigian 4
DK - Danimarca 4
EE - Estonia 4
ID - Indonesia 4
MA - Marocco 4
RO - Romania 4
UZ - Uzbekistan 4
VE - Venezuela 4
PA - Panama 3
PE - Perù 3
PT - Portogallo 3
ZA - Sudafrica 3
AU - Australia 2
BB - Barbados 2
CL - Cile 2
CR - Costa Rica 2
HU - Ungheria 2
IL - Israele 2
KE - Kenya 2
KR - Corea 2
NO - Norvegia 2
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
CG - Congo 1
CO - Colombia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MM - Myanmar 1
MT - Malta 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SA - Arabia Saudita 1
TH - Thailandia 1
UY - Uruguay 1
Totale 15.178
Città #
Chandler 1.123
Jacksonville 928
Singapore 897
Dublin 845
Southend 460
Princeton 373
Chieti 327
Izmir 298
Nanjing 265
Ashburn 243
Dearborn 228
The Dalles 206
Ann Arbor 200
Santa Clara 194
Wilmington 175
Cambridge 146
Altamura 143
Beijing 123
Pescara 105
New York 101
Nanchang 95
Boardman 87
Shenyang 67
Munich 60
Los Angeles 57
Woodbridge 53
Tianjin 52
Hebei 48
Hong Kong 48
Kunming 48
Brussels 46
Washington 42
Helsinki 35
Brno 31
Jinan 30
Grevenbroich 29
Kocaeli 29
Rome 29
Dong Ket 28
Falls Church 26
Jiaxing 26
Zhengzhou 26
Leawood 25
Milan 24
Vienna 23
Hangzhou 20
Houston 20
San Mateo 20
Seattle 20
São Paulo 20
Augusta 19
Ningbo 19
Norwalk 19
Nuremberg 18
Ancona 16
Changsha 16
Toronto 16
Bologna 15
Guangzhou 15
Lanciano 15
Ardabil 14
Auburn Hills 14
Lanzhou 14
London 14
Silvi 14
Teramo 13
Brooklyn 12
Kraków 12
Moscow 12
Düsseldorf 11
Orange 11
Turku 11
Changchun 10
Frankfurt am Main 10
Isernia 10
L'aquila 10
Orsogna 10
Romola 10
San Francisco 10
Santa Maria Imbaro 10
Simi Valley 10
Ottawa 9
Taizhou 9
Villaverla 9
Boston 8
Brasília 8
Monmouth Junction 8
Rio de Janeiro 8
Bari 7
Campomarino 7
Chicago 7
Edinburgh 7
Hefei 7
San Jose 7
Warsaw 7
Wuhan 7
Campinas 6
Catania 6
Erzurum 6
Laval 6
Totale 9.093
Nome #
Viscoelastic properties of Staphylococcus aureus and Staphylococcus epidermidis mono-microbial biofilms 180
Development of glycine-α-methyl-proline-containing tripeptides with neuroprotective properties 151
Chelating and antioxidant properties of l-Dopa containing tetrapeptide for the treatment of neurodegenerative diseases 149
Modulation of apoptotic cell death and neuroprotective effects of glutathione—L-Dopa codrug against H2O2-induced cellular toxicity 137
Synthesis of a novel cyclic prodrug of S -allyl-glutathione able to attenuate LPS-induced ROS production through the inhibition of MAPK pathways in U937 cells 136
Gold nanoparticles as scaffolds for poor water soluble and difficult to vehiculate antiparkinson codrugs 135
Preparation of boronate derivatives for the treatment of diseases and conditions associated to oxidative stress 124
Sintesi e valutazione dell’attività antimicrobica di nuovi carvacrolo codrugs 123
Memantine-derived drugs as potential antitumor agents for the treatment of glioblastoma 123
A glutathione derivative with chelating and in vitro neuroprotective activities: synthesis, physicochemical properties, and biological evaluation. 122
Preparation and characterization of polymeric micelles loaded with a potential anticancer prodrug 121
(R)-α-Lipoyl-Gly-L-Pro-L-Glu dimethyl ester as dual acting agent for the treatment of Alzheimer's disease 121
Synthesis of a novel TRH-related sulphonamido peptide 120
Zingiberene attenuates hydrogen peroxide-induced toxicity in neuronal cells 119
Solid lipid nanoparticles loaded with lipoyl-memantine codrug: preparation and characterization 119
(R)-α-Lipoyl-glycyl-L-prolyl-L-glutamyl dimethyl ester codrug as a multifunctional agent with potential neuroprotective activities 117
Sintesi di trans-2-ammino-5(o 6)-cloro-6(o 5)-idrossi-1-fenil-2,3-diidro-1H-indani quali precursori di derivati a potenziale affinità per i recettori della dopamina 115
NSAID Coniugates for the treatment of Alzheimer's Disease 115
Antiparkinson Prodrugs 114
Synthesis and preliminary pharmacological evaluation of 2,3,4,8,13a-hexahydro-1H-benzo(5,6)cyclohepta(1,2,3-ef)(3)benzazepine-6,7-diol derivatives as dopamine receptor ligands 112
Effect of MRJF4 on C6 glioma cells proliferation and migration 112
Advances in prodrug design for Parkinson's disease 111
Single-Walled Carbon Nanotubes in Highly Viscous Media: A Comparison between the Dispersive Agents [BMIM][BF4], L121, and Triton X-100 110
Carvacrol prodrugs as novel antimicrobial agents 110
Synthesis and evaluation of trans-2-amino-5(or 6)-chloro-6(or 5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands 109
Cofarmaci L-Dopa-antiossidanti solforati quali nuovi potenziali agenti anti-Parkinson 108
Carvacrol codrugs: A new approach in the antimicrobial plan 108
Toxicity assessment of hydroxyapatite nanoparticles in rat liver cell model in vitro 107
Synthesis and biological evaluation of novel analogues of Gly-l-Pro-l-Glu (GPE) as neuroprotective agents 107
sintesi ed attività di due analoghi del glutatione a conformazione ristretta 106
Au nanoparticles functionalized by newly synthetised antiparkinson prodrugs 106
Health risk assessments of lithium titanate nanoparticles in rat liver cell model for its safe applications in nanopharmacology and nanomedicine 106
Potential Antibacterial Activity of Carvacrol-Loaded PLGA Nanoparticles against Microbial Biofilm 105
Characterization of alkanoyl-10-O-minocyclines in micellar dispersions as potential agents for treatment of human neurodegenerative disorders 104
Carvacrol and its derivatives as antibacterial agents 104
Synthesis and antioxidant properties of novel memantine derivatives 104
L-Dopa Prodrugs: An Overview of Trends for Improving Parkinson's Disease Treatment 103
A novel TRH analog containing a gamma-sultam residue replacing the pyroglutamic acid 102
Synthesis and preliminary pharmacological evaluation of 5-hydroxy and 5,6-dihydroxy-benzo(5,6)cyclohept(1,2,3-ij)isoquinoline derivatives as dopamine receptor ligands 102
L-dopa co-drugs in nanostructured lipid carriers: A comparative study 102
Ibuprofen and glutathione conjugate as a potential therapeutic agent for treating Alzheimer's disease 101
Gold nanoparticles as scaffolds for new antiparkinson prodrugs 99
Sintesi di trans-2-ammino-1-fenil-5-fluoro-6-idrossi (e 6-fluoro-5-idrossi)-2,3-diidro-1H-indeni quali potenziali ligandi per i recettori dopaminergici 98
CNS delivery of L-Dopa by a new Hybrid Glutathione-Methionine peptidomimetic prodrug 98
Temporal expression of agrB, cidA and alsS in the early development of Staphylococcus aureus UAMS-1 biofilm formation and the structural role of extracellular DNA and carbohydrates 97
Synthesis and preliminary evaluation of L-dopa/benserazide conjugates as dual acting codrugs 97
Biodegradable microspheres loaded with an antiparkinson prodrug: an in vivo pharmacokinetic study 96
“Evaluation of endocrine disruptors, TPHPand DPHP, effect on DNA repair damage pathwais in a normal human thyroid cell model” 96
Synthesis of a novel glutathione analogue as potential inhibitor of glutathione-S-transferase 95
Binding and preliminary evaluation of 5-hydroxy- and 10-hydroxy-2,3, 12,12a-tetrahydro-1H-[1]benzoxepino[2,3,4-ij]isoquinolines as dopamine receptor ligands. 95
Design, synthesis and preliminary pharmacological evaluation of new imidazolinones as L-DOPA prodrugs. 95
Synthesis and Biological Evaluation of Novel Selenyl and Sulfur-l-Dopa Derivatives as Potential Anti-Parkinson's Disease Agents 95
Activity of N-(2-phenylethyl)-N-n-propyl-(2-(3-hydroxyphenyl)ethylamine derivates as dopamine receptor ligands 94
Synthesis and Study of L-Dopa-Glutathione Codrugs as New Anti-Parkinson Agents with Free Radical Scavenging Properties. 94
A new lipophilic molecular combination codrug-1 exerts neuroprotective activity in beta amyloid (1-40) infused Alzheimer’s disease rat model 94
Direct- and spacer-coupled codrug strategies for the treatment of Alzheimer’s disease 93
Novel NSAID-derived drugs for the potential treatment of Alzheimer’s disease 93
synthesis and Activity of L-Dopa-Thiol antioxidant Co-drugs and New anti-PArkinson Agents with free Radical Scavenging Properties 92
HPLC–FLD and spectrofluorometer apparatus: How to best detect fluorescent probe-loaded niosomes in biological samples 92
Synthesis and preliminary pharmacological evaluation of trans-2-amino-5(6)-chloro-6(5)-hydroxy-1- phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands 91
RNAIII Inhibiting Peptide (RIP) and derivatives as potential tools for the treatment of S. aureus biofilm infections 91
Maleic- and Fumaric-diamides of (O,O-diacetyl)-L-Dopa-methylester as anti-Parkinson prodrugs in liposomal formulation 90
Novel hydrogel and functionalized silica for dispersion of CO2 and carbon nanotube-based catalysts 90
Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases 90
Evaluation of 2,3,4,8,13a hexahydro-1H-Benzo[5,6]cyclohepta-6,7-dihydroxy[1,2,3-ef][3]benzazepine derivatives as dopamine receptor ligands 89
Design and synthesis of multifunctional drugs: a strategy to improve the treatment of Parkinson’s disease 89
Synthesis of l-(+)-3-(3-hydroxy-4-pivaloyloxybenzyl)-2,5-diketomorpholine as potential prodrug of l-dopa 89
Novel anti-Alzheimer phenol-lipoyl hybrids: Synthesis, physico-chemical characterization, and biological evaluation 89
Viscoelastic behaviour of hyaluronic acid formulations containing carvacrol prodrugs with antibacterial properties 89
Synthesis and biological evaluation of a novel pyroglutamil-modified TRH analogue 88
Ibuprofen and lipoic acid diamide as co-drugs with neuroprotective activity: pharmacological properties and effects in β-amyloid (1-40) infused Alzheimer’s disease rat model. 88
Inside Cover: Single-Walled Carbon Nanotubes in Highly Viscous Media: A Comparison between the Dispersive Agents [BMIM][BF4 ], L121, and Triton X-100 (Chem. Eur. J. 2/2016) 88
Twin amides as potential prodrugs of L-DOPA 87
Detection of levodopa, dopamine and its metabolites in rat striatum dialysates following peripheral administration of L-DOPA prodrugs by mean of HPLC-EC 87
synthesis and biological evaluation as anti-Parkinson agent of an analogue of Glutathione-L-Dopa containing methionine in place of the cysteinil residue 87
Epigenetic Memory of Early-Life Parental Perturbation: Dopamine Decrease and DNA Methylation Changes in Offspring 87
Transition state isosteres of the gamma-glutamyl peptide bond hydrolysis: synthesis and characterization of the psi (CH2NH) pseudopeptide analogue of glutathione 87
Nuovi S-coniugati del glutatione ad attività inibitoria nei confronti delle GST umane 86
Evaluation of rat striatal L-Dopa and DA concentration after intraperitoneal administration of L- Dopa prodrugs in liposomal formulations 86
NOS-mediated morphological and molecular modifications in rats infused with Aβ (1-40), as a model of Alzheimer’s Disease, in response to a new lipophilic molecular combination codrug-1 86
Memantine-sulphur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer’s disease 86
Novel hydrogels for dispersion of carbon nanotube-based catalysts 86
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 86
Graphene Oxide increases mammalian spermatozoa fertilizing ability by extracting cholesterol from their membranes and promoting capacitation 86
Role of Dietary Supplements in the Management of Parkinson's Disease 86
Codrugs Linking l-Dopa and Sulfur-Containing Antioxidants: New Pharmacological Tools against Parkinson’s Disease 85
Transdermal donepezil on the treatment of Alzheimer’s disease 85
Novel hydrogels for dispersion of carbon nanotube-based catalysts 85
Evidence for a Dopamine Intrinsic Direct Role in the Regulation of the Ovary Reproductive Function: In Vitro Study on Rabbit Corpora Lutea 85
In vitro evaluation of the potential anticancer activity of new memantin co-drugs on rat C6 glioblastoma cells 85
CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy 84
Glycosyl and polyalcoholic prodrugs of lonidamine 84
Stimulation of Human Macrophages (THP-1) using Toll-like Receptor-2 (TLR-2) Agonist Decorated Nanocarriers 84
Designing Prodrugs for the Treatment of Parkinson's Disease 84
Nanoencapsulation strategies for the delivery of novel bifunctional antioxidant/σ1 selective ligands 84
Synthesis and evalutation of N-n-propyl-N-(2-phenylethyl)-2-(3-fluoro-4-hydroxy-phenyl) ethylamine derivatives 83
New drug delivery strategies for improved Parkinson’s disease therapy 83
Ibuprofen and lipoic acid diamides as potential codrugs with neuroprotective activity 83
Preparation and pharmacological characterization of trans-2-amino-5(6)-fluoro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as D2-like dopamine receptor agonists 83
Synthesis and evalutation of 2-(5-methoxythiophen-3-yl)ethylamines as potential dopamine agonists 82
Totale 10.036
Categoria #
all - tutte 69.144
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.144


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202044 0 0 0 0 0 0 0 0 0 0 0 44
2020/20211.198 166 13 183 27 87 214 31 24 92 151 136 74
2021/2022918 33 32 13 94 93 33 34 61 131 42 89 263
2022/20233.067 235 464 178 332 280 584 153 281 367 47 66 80
2023/20241.486 99 82 102 54 94 461 318 55 20 24 27 150
2024/20253.266 192 720 616 122 50 225 100 199 312 170 472 88
Totale 15.785